Court Rejects Personalized Medicine Patents

March 21, 2012

March 21, 2012 | The US Supreme Court rejected two Prometheus patents on a method for monitoring a patient's blood to determine drug dosing. Mayo Clinic brought the patent challenge. The Supreme Court ruled that adjusting dosage based on patient monitoring was a natural process and could not be patented. The decision could threaten hundreds of patents and possibly the future of personalized medicine, some biotech representatives warned. Chicago Tribune